top of page

Profile

Join date: Sep 27, 2020

Posts

Sep 28, 2023 ∙ 3 min

Key ceftobiprole data published

Basilea announced today that the data from the ceftobiprole Phase 3 trial in patients with Staphylococcus aureus (S. aureus) bacteraemia...

97

0

Aug 15, 2023 ∙ 3 min

Basilea - H1 results and upgrade

The continued growth of the Cresemba franchise, along with a planned reduction in R&D spending, has taken Basilea into a period of...

121

0

Aug 4, 2023 ∙ 2 min

Basilea - ceftobiprole filed for US approval

Basilea announced this morning that its 5th generation cephalosporin antibiotic ceftobiprole has been filed for approval in the key US...

124

0

B

Brian White

Writer

More actions

bottom of page